The Itch Clinic®

Chattanooga

(temporarily closed)

Animal ER and Speciality Center

6393 Lee Hwy, Chattanooga, TN 37421

(800) 621-1370

FDA requests that Zoetis immediately cease the dissemination of the items that fail to accurately represent the risks associated with APOQUEL. 

=================

Warnings:

APOQUEL is not for use in dogs less than 12 months of age (see Animal Safety). APOQUEL modulates the immune system.

APOQUEL is not for use in dogs with serious infections.

APOQUEL may increase susceptibility to infection, including demodicosis, and exacerbation of neoplastic conditions (see Precautions, Adverse Reactions, Post-Approval Experience and Animal Safety).

New neoplastic conditions (benign and malignant) were observed in dogs treated with APOQUEL during clinical studies and have been reported in the post-approval period (see Adverse Reactions and Post-Approval Experience).

Allergy immunotherapy (also known as “desensitization,” “allergy vaccination,” or “hyposensitization”) is the process of administering injections to a pet in order to make them more tolerant of allergens. Common allergens are house dust mites, grass pollens, weed pollens, tree pollens, and fungal spores. Veterinarians have used immunotherapy for over 30 years to treat pets with skin allergies (atopic dermatitis or “AD”). Immunotherapy provides significant relief from itching to most pets with allergies (about 75% respond to treatment). The selection of ingredients is traditionally based on either a blood test or an intradermal test (“skin test”). To perform an intradermal test, pets are sedated or anesthetized and 50-70 different allergens are injected into the skin. A red swelling is interpreted as meaning the pet is possibly allergic to that allergen.